Background/Aims: Let-7b was dramatically reduced after a dicer knockout of mice with intestinal barrier function injuries. This paper aims to investigate the molecular mechanism of let-7b by targeting p38 MAPK in preventing intestinal barrier dysfunction. Methods: A total of 186 patients were enrolled, with 93 in the control group and 93 in the PRO group. Only 158 patients completed the entire study, whereas the others either did not meet the inclusion criteria or refused to participate. To further verify the role of let-7b, intestinal epithelial conditional knockout (IKO) mice of mmu-let-7b model were established. Serum let-7b, zonulin, IL-6, and TNF-α concentrations were measured by ELISA or quantitative RT-PCR. Permeability assay was done by ussing chamber. The apoptotic cells were identified using an In Situ Cell Death Detection Kit. Protein was detected by western blot. Results: Probiotics can lower infectionrelated complications, as well as increase the serum and tissue let-7b levels. P38 MAPK was identified as the target of let-7b, as verified by NCM460 cells. P38 MAPK expression was increased, whereas tight-junction (TJ) proteins were significantly decreased in let-7b IKO mice (both P<0.05). Negative regulation of p38 MAPK molecular signaling pathways was involved in
Introduction
Our previous study found that perioperative probiotic treatments can reduce postoperative septicemia, which is associated with decreased serum zonulin levels of patients undergoing colectomy [1] . Zonulin can be a biomarker of the intestinal epithelial permeability.
MiRNAs act as negative regulators of gene translation by binding to 3′untranslated regions (3′-UTRs) of the target gene and silencing their mRNA target gene effectively [2] . MiRNAs are involved in the expressional regulation of various genes [3] . Hundreds of miRNAs have been described in humans, and an estimate of no less than 1000 miRNAs have been encoded by the human genome [4] . MiRNAs are involved in the regulation of gene expression in numerous critical biological processes [5] , such as development, differentiation, apoptosis, and proliferation [6] . Upon structural analysis, the pre-translational level governance of miRNAs has been estimated to affect half of the human transcripts, whereas functional studies indicated that miRNAs might participate in almost every cellular process investigated to date [7] . Hitherto, only a few studies have investigated the relationship between miRNAs and intestinal epithelial barrier dysfunction [8, 9] . No clinical interventions for exploring the relationship between let-7b and intestinal barrier have been performed as well. McKenna et al. determined the complete miRNA expression profile of the contribution of miRNAs to intestinal homeostasis using Villin-Cre mutant mice [10] . Intestinal barrier function was impaired in Dicer1-deficient mice, resulting in intestinal inflammation with lymphocyte and neutrophil infiltration. After dicer knockout in mice, mmu-let-7b was dramatically reduced. However, the molecular mechanism was not further investigated.
Few studies have investigated the relationship between let-7b and intestinal barrier dysfunction. Therefore, we hypothesize that let-7b is important in protecting intestinal barrier function. In this study, we aim to investigate the molecular mechanisms of the let-7b by targeting p38 MAPK to protect the intestinal epithelial barrier.
Materials and Methods

Inclusion and exclusion criteria
All patients with suspected colorectal cancer underwent routine physical examination, laboratory tests, and imaging studies, including colonoscopy, three-phase contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI). The final diagnosis made by the combination of medical history, physical examination, and relative examinations [11] .
As described in our previous study [1] , the following inclusion criteria were used: (1) patient aged between 25 and 75 years, (2) confirmed diagnosis via biopsy and histological testing, (3) patients underwent a radical resection, and (4) they had no distant metastases.
The exclusion criteria were: (1) patient aged over 75 years, (2) patient was pregnant, (3) known lactose intolerance, (4) clinically significant immunodeficiency, (5) additional gastrointestinal disorders (e.g., Crohn's disease or ulcerative colitis), (6) received antibiotics for 10 days before surgery, (7) evidence of infection, (8) no other pre-or probiotic or excessive fiber intake within 2 weeks of surgery, (9) the patient underwent an emergency operation, (10) bowel preparation for colonoscopy within 6 days prior to surgery, (11) the patient underwent a proctectomy with low rectal anastomosis or surgery for a polypoid lesion, (12) the surgery was performed laparoscopically, (13) patients received preoperative neoadjuvant chemotherapy or radiotherapy, and (14) the patient had a distant metastasis.
Patients
Between April 2011 and December 2015, 186 colorectal cancer patients who were scheduled to undergo a radical colectomy at one of the two centers were enrolled in the study. The centers were the Shanghai Sixth People's Hospital and the Sixth Affiliated Hospital of Sun Yat-sen University in Guangzhou. Prior to surgery, the patients were randomly assigned to either the placebo control group (controls, with perioperative oral feeding with a placebo) or the probiotics therapy group (PRO, with perioperative PRO treatment). The study design and protocols were reviewed and approved by the Human Research Review Committee of both the Sixth Affiliated Hospital of Sun Yat-sen University and the Shanghai Sixth People's Hospital (2011006). Written informed consent was obtained from each patient before enrollment.
In our study, 196 patients were assessed for eligibility. Only 186 patients were enrolled, whereas 10 patients were excluded either because they did not meet the inclusion criteria or refused to participate. Only 158 patients completed the entire study. Among 186 patients, 93 were included in the control group, whereas 93 were in the PRO group (Fig. 1) . Among 158 subjects who completed the trial, 79 were in the control group and 79 were in the PRO group. No significant differences were found regarding the baseline of patients between both groups (Table 1) .
Study design, PRO treatment, and patient care As previously described (1), computer-generated random allocation schedule was used for the randomization of groups. The treatment assignment was only known to a nurse who was not directly involved in the trial and who could have broken the treatment codes in the event of an emergency.
As mentioned in our previous study [1] cfu/g), 1.5 g/day, at a total daily dose of 5.0×10 8 cfu. An acid-resistant coating was used to prepare the capsules containing the PRO and placebo. Patients in the control group received daily encapsulated maltodextrin. The appearance of the two types of capsules, as well as the smell and taste of the study substances, were the same.
The intervention period lasted for 16 days, i.e., 6 days preoperatively and 10 days postoperatively. All the subjects were interviewed by the study nurse, and any reactions to the product or medications taken, as well as adverse events that occurred within the16-day period, were recorded, same with our pervious study [1] .
We collected patient specimens and clinical data to determine the levels of let-7b (serum and tissue), serum zonulin, IL-6, and TNF-α.
Measurement of serum let-7b, zonulin, IL-6, and TNF-α concentrations
Serum collected 24 h postoperatively were evaluated using an ELISA kit to determine zonulin, IL-6, and TNF-α, as previously described [12] . Briefly, plastic microtiter plates (Costar, Cambridge, MA) were coated with rabbit zonulin cross-reacting Zot derivative ΔG IgG antibodies (10 µg/ml in 0.1 mol/l sodium carbonate buffer, pH 9.0), which were generated according to previously described methods [12, 13] . A color reaction was developed using a commercial kit (ELISA amplification kit; Invitrogen). The absorbance at 495 nm was measured with a microplate auto-reader (Molecular Devices Thermomax Microplate Reader). The concentration of let-7b was determined by polymerase chain reaction (PCR), as described below. The samples of the normal colonic segments were collected during surgery (>5cm from the tumor).
Cell culture NCM460 cells were purchased from INCELL Corporation (San Antonio, TX, USA) and grown in M3 media supplemented with 10% FBS, 100U/ml penicillin, and 100 µg/ml streptomycin at 37 °C in a humidified atmosphere containing 5% CO 2 . Cells were passaged at pre-confluent densities using 0.05% trypsin and 0.5 mm EDTA (Gibco, USA), as previously described [1] .
Transfection NCM460 cells with let-7b overexpression Lentivirus
The let-7b cDNA was synthetizedusing a real-time (RT)-PCR kit with F: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGaaccaca R: ACACTCCAGCTGGGtgaggtagtaggttg as primers. Total RNA was isolated using TRIzol Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. Recombinant plasmid DNA or the control empty vectorwas purified with a Qiagen plasmid kit (Qiagen, Valencia, CA, U.S.A.). Lentivirus was prepared as described [14] and was used for the transfection of NCM460 cells. The insertion orientation was confirmed by sequencing. After transfection using Tfx-50 reagent (Promega), cells were cultured in the presence of G418, and the G418-resistant colonies were picked 2 weeks later. Cell clones were expanded individually and the clones that expressed high let-7b levels were selected.
Build and identify let-7b intestinal-specific knockout mice
To obtain let-7b intestinal-specific knockout mice, a targeting vector for generating null alleles of let7b deletion mutation was established using the pBR322 vector, which contained a neomycin resistance gene driven by the pGK promoter and flanked by FRT sites. The let-7b targeting process replaced the pre-miR sequences flanked by loxP sites with neomycin resistance gene. The targeting vector contained the loxPflanked let-7b cassette. Cre-lox technology was used to generate conditional knock-out mice as described [15] . Targeting vectors were subsequently linearized and electroporated into ES cells. Positive clones with appropriatelet-7b alleles were injected into C57BL/6 blastocysts, and >50% chimeric male mice were crossed with C57BL/6 females to generate Flox+/+ mice. Flox+/+ mice were intercrossed with Villin-Cre transgenic mice (J000664, Jackson laboratories) to remove let-7b in IECs and generate let-7b intestinalspecific knockout mice. These mice were back crossed to C57BL/6 mice for more than eight generations for the relevant mutation. Mice were bred and kept at Sun Yat-Sen University Laboratory Animal Center (Guangzhou, China). All of the mice were raised under specific pathogen-free conditions with filtered air and were fed with rodent chow ad libitum, with free access to water. Genotyping of mice with conditional depletion of let-7b in epithelial cells was performed by PCR with genomic DNA isolated from the tail using Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry a tissue DNA isolation kit (Biomiga, China). Animal studies were approved by the Animal Care Committee of Sun Yat-Sen University. The methods were done in accordance with the approved guidelines for both animal and patient studies.
Histopathological score of the mice colon tissue
Colons of mice were excised and cut into three equal segments and labeled distal, middle, and proximal colons. Tissues were fixed with 10% neutral formalin, embedded in paraffin, sectioned at 4µm, and stained with hematoxylin and eosin (H&E). Blind analysis was done to the tissue sections by two trained gastroentero-pathologists. Inflammatory infiltrate was scored using two types of criteria, namely, severity and extent of injury and character of infiltrate, where in the infiltrating leukocyte extent/severity score equals the area of involved plus the score of severity per intestinal layer. Histopathological changes were scored on a scale of 0-3 (where 0=none; 1=mild; 2=moderate; 3=severe) for each parameter. The involved areas were scored as follows: 0=no involvement; 1 ≤ 25% of section; 2 ≤ 50%; 3 ≤ 75%; 4 ≤ 100%. A score was determined for each part of the colon. Total scores were the sum of the scores of each segment, as previously described [16] .
Permeability assay
Ussing chamber assay was used to determine the intestinal permeability measurement in isolated mice colons. Tissue ion resistance (1/G, where G represents the conductance) was calculated from the potential difference and short circuit current according to Ohm's law [17] .
TUNEL assay
Formalin-fixed sections of mice colon tissue were deparaffinized in xylene and hydrated in an alcohol gradient. The apoptotic cells were identified using an In Situ Cell Death Detection Kit (Roche, Switzerland) according to the manufacturer's instructions. Slides were observed under fluorescent microscopy (Leica DMI4000B, Germany).
Luciferase assay
The NCM460 cells were transfected with oligonucleotides using Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer's instructions. The genomic region 3′-UTR site of p38 MAPK was amplified using the primer (sense: 5′-AACTCGAGCGAGTCCTCTCCTAGGACTA-3′, and antisense: 5′-TTGCGGCCGCACACAAAGCTTAAATATG-3′). The resulting fragments containing intact putative let-7b recognition sequences from the 3′-UTR of p38 MAPK or with random mutations were cloned in the psi-CHECK2 vector (Promega). NCM460 cells were co-transfected using Transit-TKO (Invitrogen) with the reporter plasmids and either the p38 MAPK wild type (WT) or mutant (MUT) vector. Luciferase assays were done 48 h post-transfection following the manufacturer's protocol (Dual-luciferase reporter assay system, E1910; Promega). Firefly luciferase activity was normalized to Renilla luciferase activity for each sample. A total of 2.0×10 4 cells in 24-well plates were co-transfected with 0.5 µg psiCHECK-2 Renilla luciferase construct, 20 µM of the let-7b precursor, or the corresponding control. Passive lysis buffer (100 µL per well) was added 48 h after transfection. The luciferase activities were measured using a Dual-Luciferase Report System (Promega).
Quantitative RT-PCR analysis
First strand synthesis of cDNA was performed using the Reverse Transcription Kit (Invitrogen, USA). A quantitative RT-PCR (qRT-PCR) for mRNA was performed using SYBR Master Mix (Invitrogen, USA) according to the manufacturer's instructions using a 7500 Real-Time PCR system.
qRT-PCR primer sequences were as follows: 
Western blot analysis For Western blot analysis, proteins were separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and transferred to polyvinylidenedifluoride (PVDF) membranes (Millipore, Massachusetts) using a wet electroblotter (Bio-Rad) for 120 min at 100 V. The membrane was then incubated with the appropriate primary antibody at 4°C overnight, washed thrice (10 min each time) with Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS-T buffer), and incubated for 1 h with the appropriate HRP-conjugated secondary antibody in TBS-T buffer for 4 h at 4°C. The membrane was washed thrice (60 min each time) with TBS-T buffer and developed using the enhanced chemiluminescence method (ECL kit; Pierce, Illinois) according to the manufacturer's instructions [18] .
Statistical analysis
A sample size calculation based on the published prevalence of bacterial translocation (BT) demonstrated that approximately 44 patients were required in each group to demonstrate a reduction in BT from 15% to 0% at a 5% significance level with a power of 80%, as previously reported [1] . Results were analyzed using SPSS13.0 version for Windows (SPSS, Chicago, Illinois, USA). Quantitative data were expressed as the mean ± standard deviation. For post-operative clinical tests, the numerical data were compared by t-tests and nominal data were analyzed between the groups using Pearson χ 2 or Fisher's exact test. A Pvalue <0.05 was considered statistically significant.
Results
Low expression levels of let-7b, occludin, and Zo-1 at mRNA levels and high levels of IL-6 and TNF-α (serum) detected in clinical samples
Postoperative infection-related parameters, such as septicemia, diarrhea incidence, duration of postoperative pyrexia (>38.5 °C), and cumulative duration of antibiotic therapy were significantly different between the PRO and control groups; these data are same with those in our previous study [1] (Table  2) . Moreover, the PRO group showed significant advantages.
Moreover, clinical samples were used to investigate the clinical features of let-7b. Fresh colon tissues (>5cm from the tumor) and serum that was collected 24 h after the operation were used for the determination of tissue let7b expression level using qRT-PCR. The expression level of let-7btissues of the PRO group was significantly higher than that of the control group (P<0.001, Table 2 ), whereas the serum let-7b of the PRO group was Table  2 ). The zonulin level of the PRO group was reduced after PRO treatment ( P < 0 . 0 5 , Table 2 ). The e x p r e s s i o n level of let7b was d e t e r m i n e d before PRO t r e a t m e n t and before d i s c h a r g e from the hospital, and no significant difference was found between the two groups (P>0.05).
To link the clinical study to the basic research, the mouse model was used to determine the expression levels of let-7b and other factors. C57BL/6 let-7b intestinalspecific knockout mice (10 from each group) were administered with PRO bacteria and normal saline treatment 3 days before surgery. The colectomy of 2 cm colon of colorectal cancer patients was performed in each group and the left colon was re-constructed. Fresh colon tissues (>5 cm from the tumor) and serum that was collected 24 h after the operation were used for the determination. Results showed that let-7b cannot be detected both in the tissue and serum, whereas serum IL-6 (2.62±1.16) and TNF-α (8.21±1.96) was significantly lower after PRO administration, compared with the control group (IL-6, 1.55±1.08; TNF-α, 3.62±1.86, P< 0.05). 2 . p38 MAPK is a target gene of let-7b. A NCM460 transfected with let-7b precursor showed higher expression level of let-7b detected by quantitative real time polymerase chain reaction; B NCM460 transfected with let-7b precursor showed lower expression level of p38 MAPK detected by quantitative real time polymerase chain reaction; C Analysis of the relative luciferase activity in NCM460 cells co-transfected with pGL3-p38 MAPK 3'UTR-wild and let-7b precursor showed lower luciferase compared with the control, whereas the mutant did not indicate significant defference; D NCM460 transfected with let-7b precursor showed lower expression level of p38 MAPK detected by western blot, whereas transfected with let7b inhibitor showed higher level; E NCM460 transfected with let-7b inhibitor showed lower let-7b and higher expression level of p38 MAPK detected by quantitative real time polymerase chain reaction; NCM460 transfected with let-7b inhibitor showed higher expression level of p38 MAPK detected by western blot; * vs Control, P<0.05; ** vs Control, P<0.05. n=3 for each of the group.Quantitative data are expressed as the mean ± standard deviation. Numerical data were compared by t-tests. 
Identification of p38 MAPK as a let-7b target
First, the target let-7b binding site was predicted using three different computational programs, namely, TargetScan (http://www. targetscan.org/) [19] , PicTar (http://pictar.mdc-berlin.de/cgibin) [20] , and miRanda (http:// www.microrna.org/) [21] . After three lists were generated by the three computational programs, a fourth list, which contained genes predicted by all the three initial computational programs (Table 3) , was generated from the analysis of bioinformatics with the MetaCore TM platform. The MAPK signal pathway was selected as the target molecular signal for further analysis because our previous study indicated p38 MAPK to be involved in the regulation of intestinal permeability and the intestinal barrier function [18] . Therefore, we investigated the interaction of let-7b with p38 MAPK.
To confirm target specificity between let-7b and p38 MAPK, we performed a dual-luciferase reporter assay using vectors containing the let-7b precursor (PRE) and mutated let-7b binding site (MUT). The relative luciferase reporter activity of NCM460 cells, which were let-7b precursors co-transfected with p38 MAPKWT, was significantly lower than NCM460 cells, which were transfected with MUT (Fig.  2C) . Furthermore, NCM460 cells were transfected with the let-7b precursor. Moreover, Western blot analysis showed that let-7b can downregulate the expression level of p38 MAPK in the NCM460 cell line transfected with the let7b precursor, compared with the control group that was transfected with the empty vector (Figs. 2A, B, D) . Opposite results were detected after the let-7b inhibitor was transfected with NCM460 cells (Figs. 2E, F) . The western blot analysis demonstrated that let-7b precursor transfection leads to a significant expression increase of occludin; Akt signal was not impacted, while phosphorylated Akt was increased significantly. NF-KB was also not impacted. PTEN and BAX expression levels were decreased, while Bcl-2 expression levels were elevated in let-7b overexpression NCM460 cell line compared with control. The biological material was purchased from Univ and Abcam.
GFP
Let-7b overexpression Fig. 4 . TJ associated proteins detected in let-7b IKO mice, such as occludin, Zo-1, and PP2A. A let-7b was lower in the let-7b IKO mice, detected by quantitative real time polymerase chain reaction; B The expression level of p38 MAPK was higher in let-7b IKO group, compared with theFlox+/+ group, detected by quantitative real time polymerase chain reaction; C The expression level of occludin, Zo-1, and PP2A was significantly decreased in let-7b IKO group than Flox+/+ group detected by Western Blot, while p38 MAPK was increased. n=10 for each of the group. Numerical data were compared by t-tests. 
Let-7b expression level correlates with expression level of TJ protein
The western blot analysis demonstrated that let-7b precursor transfection leads to a significant increase of the expression level of occludin, which plays a key role in intestinal barrier, compared with the control (Fig. 3) . Expression level of AKT was not changed after let-7b precursor transfection, whereas phosphorylated Akt was increased significantly, indicating that AKT signal might be activated through phosphorylation (Fig. 3) . NCM460 cells were used in our study.
We performed in vivo experiments on let-7b intestinal epithelial conditional knockout (IKO) mice by detecting the expression levels of TJ-related proteins, such as occludin, Zo-1, and PP2A. The expression level of p38 MAPK was higher in the let-7b IKO group compared with the Flox+/+ group (Figs. 4B, C) . The expression levels of occludin, Zo-1, and PP2A were significantly decreased in the let-7b IKO group compared with the Flox+/+ group. These data are consistent with the outcomes in NCM460 cell lines (Fig.4C) .
Let-7b IKO mice exhibit intestinal inflammatory response and phenotypes of impaired intestinal barrier
As mentioned above, we have established the let-7b-IKO mice model. Using this model, we initially verified the effects of let-7b on the intestinal barrier. The body weights of let-7b (Fig. 5C ) with quantification by pathologist of the H&E (Fig. 5B) . Moreover, the high mortality rate of the let-7b IKO mice was observed. The histological scores of let7b IKO mice at 4, 8, and 12 weeks were significantly larger than those of Flox+/+ mice during the same week (P<0.05, Fig. 5B ). To investigate the consequence in cell apoptosis, we performed a TUNEL assay of paraffin-embedded mice intestinal tissue. Intestinal epithelial cell apoptosis of let-7b IKO mice was more severe than that of Flox+/+ mice of the same age (Fig. 5D ). Furthermore, qRT-PCR assay revealed that occludin and Zo-1 expression levels in the intestinal epithelial cells, in terms of mRNA levels,were lower in let-7b IKO mice compared with Flox+/+ mice, whereas those of IL-6 and TNF-α at the mRNA levels of intestinal epithelial cells were significantly higher in the let7b IKO mice relative to the Flox+/+ mice (P<0.05, Fig. 5E ).
Signal pathways and apoptotic proteins detection in vivo and in vitro
In our study, the let-7b IKO mice exhibited intestinal inflammatory responses with elevated levels of IL-6 and TNF-α. Thus, Western blot analysis was performed on colon tissues oflet-7b IKO mice. No change was found in the NF-κB signal pathway of the let-7b IKO mice (Fig. 6A) . Elevated phosphorylated Jun N-terminal kinase (JNK) were verified in the colon tissues of let-7b IKO mice. PTEN and BAX expression levels were elevated, whereas the phosphorylated AKT and Bcl-2 expression levels were lower in colon tissues of let-7b IKO mice compared with Flox+/+ mice (Figs. 6B, C) . In in vitro experiments using the let-7b overexpression NCM460 cell line lentivirus transfected above indicated that the PTEN and BAX expression levels were decreased, whereas the phosphorylated AKT and Bcl-2 expression levels were higher in the let-7b overexpression NCM460 cell line compared with the control (Fig. 3) . Furthermore, we determined the CD45 using the western blot staining. Result showed that CD 45 expression was higher in the Let-7b-IKO group, compared with the control (Fig. 6D) .
Discussion
The expression level of let-7b was determined before PRO treatment and before discharge from the hospital. No significant difference was found between the two groups (P>0.05). We think that the expression level was recovered to the normal level in the two groups before discharge.
We further investigated the role of let-7b on the intestinal barrier using cell lines and let-7b IKO mice. Our work showed that let-7b targets the p38 MAPK pathway in normal 
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Cellular Physiology and Biochemistry intestinal cells and animals, thereby upregulating the TJ proteins, such occludin, at the mRNA and protein levels. Moreover, the knockout of let-7b can downregulate the expression levels of occludin and ZO-1, which are both important TJ proteins that might be inhibited by the p38 pathway. The target gene was predicted using three different computational programs, TargetScan, PicTar, and miRanda. Through bioinformatics analysis using the MetaCore TM platform, p38 MAPK was selected as the target, which was reported previously as a positive regulator during intestinal barrier dysfunction [1, 18] . Dual-luciferase reporter assay indicated the p38 MAPK as a target of let-7b. Western blot indicated that let-7b can downregulate the expression level of p38 MAPK; moreover, the protective role of let-7b on intestinal barrier was observed and is consistent with our hypothesis.
In our study, the TUNEL assay of formalin-fixed mice colon tissue sections indicated that let-7b IKO mice displayed a significantly higher number of apoptotic intestinal epithelial cells compared with Flox +/+ mice. The PTEN expression level was elevated and the phosphorylated AKT expression level was decreased in let-7b IKO mice. Moreover, the results of let-7b overexpression in NCM460 cell line indicated the decrease of PTEN and increased phosphorylated AKT. Therefore, the PTEN-PI3K/AKT pathway is involved in the apoptosis of intestinal epithelial cells through the downregulation of the PTEN expression through let-7b binding with p38 MAPK [22] . PTEN is among the most commonly lost tumor suppressors in human cancers. Studies mentioned above showed that let-7b has important regulatory functions in the development or maintenance of the neoplastic state [2] . Knockdown of let7b in cultured glioblastoma cells can trigger the activation of caspases and increase apoptotic cell death. Therefore, let-7b might be an anti-apoptotic factor through its inhibition of the expression level of PTEN, which can cause TJ alteration and intestinal barrier dysfunction by accelerating the IECs apoptosis [23] . Elevated levels of inflammatory cytokines, such as IL-6 and TNF-α, were observed in let-7b IKO mice. This phenomenon might be caused by intestinal barrier dysfunction because no change was found in the NF-κB p50 and NF-κBp65 expression levels. The result where in the phosphorylated JNK was increased in let-7b IKO mice further verified that MAPK pathway maybe involved in the intestinal inflammation response of let-7b IKO mice. Elevated cytokines induced MAPK activation, which evoked the intestinal inflammation response [18] . The let-7b-mediated crosstalk between IRS-2/ Akt and MAPK is involved in oral squamous cell carcinoma by targeting insulin-like growth factor [24] . However, no study has investigated the relationship of let-7b and p38 MAPK on the aspect of the intestinal barrier. These findings revealed that let-7b inhibits p38 MAPK signaling, which is a vital signal in the activation of the intestinal TNF-α and INF-γ secretions. These secretions lead to the injury and permeability of intestinal epithelial cells and TJ [25] that contribute to the protection of normal intestinal epithelial barrier function [26] [27] [28] . Furthermore, ERK and phosphorylated ERK were lower in let-7b IKO mice compared with the control group. As an important factor in the signal transduction pathways, ERK can directly interact with the C-terminal region of occludin and protect TJ from epithelial growth factor-mediated oxidative stress [29] . Moreover, interaction of ERK can mediate the phosphorylation of certain TJ-associated proteins and signaling molecules associated with the TJ-associated proteins, thereby maintaining the integrity of the TJ and epithelial barriers [30] . Activation of ERK can induce phosphorylation of the pre-apoptotic protein Bad, which might decrease the affinity of Bad to Bcl-XL, promote the dissociation of Bad from Bcl-XL, and protect intestinal epithelial cells from death [31] . Furthermore, simultaneous activation of ERK and PI3K/Akt signaling pathways can upregulate the anti-apoptotic protein surviving [32] . From this perspective, let-7b may exert its protective effects on IECs thorough the MAPK pathway.
Conclusion
In conclusion, in the present study, we identified P38 MAPK as the target of let-7b and investigated whether let-7b plays a positive role on intestinal barrier protection by targeting 
